Monitoring of chronic myelogenous leukemia patients by semiquantitative BCR-ABL protein detection in peripheral blood mononuclear cells.

被引：0
|
作者：
Schleuning, M
Mittermüller, J
Kolb, HJ
机构：
[1] Univ Munich, Klinikum Grosshadern, Med Klin 3, D-8000 Munchen, Germany
[2] GSF, Inst Klin Hamatol, Munchen, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 1998年 / 26卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
414
引用
收藏
页码：794 / 794
页数：1
相关论文
共 50 条
  • [31] Molecular Monitoring of BCR-ABL Transcripts in Patients With Chronic Myelogenous Leukemia: Is High Sensitivity of Clinical Value?
    Maxim Norkin
    Charles A. Schiffer
    Current Hematologic Malignancy Reports, 2010, 5 : 88 - 94
  • [32] Molecular monitoring of the treatment of patients with BCR/ABL (+) chronic myelogenous leukemia
    Ruiz-Argüelles, GJ
    López-Martínez, B
    Ramírez-Cabrera, JM
    Reyes-Núñez, V
    Rodríguez-Cedeño, HM
    Garcés-Eisele, J
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2001, 53 (03): : 235 - 239
  • [33] Enhanced and Selective Killing of Chronic Myelogenous Leukemia Cells with an Engineered BCR-ABL Binding Protein and Imatinib
    Constance, Jonathan E.
    Woessner, David W.
    Matissek, Karina J.
    Mossalam, Mohanad
    Lim, Carol S.
    MOLECULAR PHARMACEUTICS, 2012, 9 (11) : 3318 - 3329
  • [34] Imatinib-resistant activation of β-catenin by BCR-ABL in a murine model of chronic myelogenous leukemia stem cells.
    Minami, Yosuke
    Stuart, Scott
    Ikawa, Tomokatsu
    Banno, Asoka
    Hunton, Irina
    Willert, Karl
    Murre, Cornelis
    Jamieson, Catriona
    Wang, Jean Y. J.
    BLOOD, 2006, 108 (11) : 603A - 603A
  • [35] Comparison studies of quantitative BCR-ABL protein expression and cytogenetic analyses in chronic myelogenous leukemia patients
    Guo, JQ
    Lian, JY
    Talpaz, M
    Deisseroth, AB
    Arlinghaus, RB
    BLOOD, 1995, 86 (10) : 154 - 154
  • [36] Induction of BCR-ABL mutations for acquired resistance in chronic myelogenous leukemia cells by imatinib
    Yuan, Hongfeng
    Gao, Chunggang
    Bhatia, Ravi
    Chen, WenYong
    CANCER RESEARCH, 2009, 69
  • [37] Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia
    Krämer, A
    Löffler, H
    Bergmann, J
    Hochhaus, A
    Hehlmann, R
    LEUKEMIA, 2001, 15 (01) : 62 - 68
  • [38] Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia
    A Krämer
    H Löffler
    J Bergmann
    A Hochhaus
    R Hehlmann
    Leukemia, 2001, 15 : 62 - 68
  • [39] BCR-ABL - AN ANTI-APOPTOSIS GENE IN CHRONIC MYELOGENOUS LEUKEMIA
    COTTER, TG
    LEUKEMIA & LYMPHOMA, 1995, 18 (3-4) : 231 - 236
  • [40] RAS IS ESSENTIAL FOR TRANSFORMATION BY THE BCR-ABL ONCOGENE OF CHRONIC MYELOGENOUS LEUKEMIA
    SAWYERS, CL
    MCLAUGHLIN, J
    HAVLIK, M
    WITTE, O
    BLOOD, 1993, 82 (10) : A331 - A331
12345